HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dipyridamole-associated shock and pulmonary edema.

AbstractOBJECTIVE:
To report a case of fulminant shock and noncardiogenic pulmonary edema induced by intravenously administered dipyridamole.
CASE SUMMARY:
A 73-year-old woman presented to the office of her cardiologist for dipyridamole myocardial scintigraphy. Several minutes after administration of intravenous dipyridamole 0.57 mg/kg over 4 minutes she developed wheezing, followed by cardiovascular collapse and pulmonary edema requiring 100% oxygen and endotracheal intubation. She had never received dipyridamole before this, and no other medications or exposures were documented proximate to the collapse. On transfer to the hospital, she developed shock refractory to multiple vasopressors, which responded to continuous infusions of epinephrine. She also had severe pulmonary edema requiring invasive ventilation, 100% inspired oxygen, and 24 cm H₂O positive end-expiratory pressure. An echocardiogram did not show new left-ventricular dysfunction and there were signs of right-heart underfilling, supporting a diagnosis of noncardiogenic pulmonary edema. Both shock and pulmonary edema resolved within 12 hours.
DISCUSSION:
Dipyridamole-associated hypotension has been reported in a number of case series and registries. Detailed case descriptions, however, are not available in the literature to permit understanding of the mechanism of shock following hypotension resulting from dipyridamole myocardial scintigraphy. Our case is exceptional in that echocardiography results support a diagnosis of hypovolemic (rather than cardiogenic) shock. To our knowledge, this is the first case of severe (most likely noncardiogenic) pulmonary edema associated with intravenous infusion of dipyridamole. An objective causality assessment suggested that this patient's cardiopulmonary collapse was probably related to dipyridamole.
CONCLUSIONS:
While hypotension has been previously associated with intravenous use of dipyridamole, ours is the first report to suggest a noncardiogenic mechanism for shock. To our knowledge, this is the first reported case of noncardiogenic pulmonary edema following dipyridamole infusion.
AuthorsMaria Dioverti, Robert Fishman, Robert Moskowitz, Sixto A Arias, Sumi Nair, Priyanka Lall, Adam E Schussheim, Stuart Zarich, Constantine Manthous
JournalThe Annals of pharmacotherapy (Ann Pharmacother) Vol. 45 Issue 7-8 Pg. e42 (Jul 2011) ISSN: 1542-6270 [Electronic] United States
PMID21672887 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vasodilator Agents
  • Dipyridamole
Topics
  • Aged
  • Dipyridamole (administration & dosage, adverse effects)
  • Female
  • Humans
  • Infusions, Intravenous
  • Myocardial Perfusion Imaging (adverse effects)
  • Pulmonary Edema (etiology, therapy)
  • Shock (chemically induced, physiopathology, therapy)
  • Treatment Outcome
  • Vasodilator Agents (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: